Despite a U.S. factory mixup, more Johnson & Johnson doses are becoming available in the U.S., marking the only single-shot vaccine option. So how effective is it and how does it compare to the Pfizer ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

With three coronavirus vaccines already approved for emergency use authorization in the U.S., how do the different available shots compare? Pfizer and Moderna's COVID vaccines have been available in ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...

The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson. The US Food and Drug Administration has given the vaccine emergency use authorization, the Centers ...

CHICAGO (WLS) -- The Johnson & Johnson vaccine continues to be put on hold after a CDC panel said it needs more time to look into claims of dangerous blood clots. The United Center mass vaccination ...

Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology, which underpinned its COVID-19 vaccine, was valid and that Pfizer and BioNTech’s ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations for COVID-19 shots developed by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) ...

(WGHP) — As states expand eligibility for COVID-19 vaccinations to more and more people, some are beginning to wonder why the age requirement isn’t consistent across the three currently approved ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...